 | |
 | |
| Clinical data | |
|---|---|
| Trade names | Caprosem |
| Other names | Testosterone 17β-chloral hemiacetalO-acetate; 17β-(1-(Acetyloxy)-2,2,2-trichloroethoxy)androst-4-en-3-one |
| Routes of administration | Intramuscular injection |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C23H31Cl3O4 |
| Molar mass | 477.85 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Cloxotestosterone acetate (INNTooltip International Nonproprietary Name; brand nameCaprosem), also known astestosterone 17β-chloral hemiacetalO-acetate, is asynthetic,injectedanabolic–androgenic steroid (AAS) and anandrogen ether and ester – specifically, theO-acetateester ofcloxotestosterone, the 17β-trichlorohemiacetalether oftestosterone.[1] It is administered viaintramuscular injection, as a 100 mg, 2 mLaqueous suspension and lasts 4 to 6 weeks with a single administration.[2][unreliable source?] The drug was first marketed in the early 1960s.[2]
 | Thisdrug article relating to thegenito-urinary system is astub. You can help Wikipedia byexpanding it. |
